Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Travere Therapeutics, Inc. | 118,658 | reported | 06 May 2026 | tx 43+461,390−80,708 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 4,250 | 0.00 USD | 10b5-1 |
| 05 May 2026 | SALE | Travere Therapeutics, Inc. | 2,181 | 46.65 USD | 10b5-1 |
| 06 May 2026 | SALE | Travere Therapeutics, Inc. | 310 | 43.95 USD | 10b5-1 |
| 04 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 8,500 | 0.00 USD | 10b5-1deriv |
| 04 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 4,250 | 0.00 USD | 10b5-1deriv |
| 04 Feb 2026 | SALE | Travere Therapeutics, Inc. | 110 | 32.90 USD | |
| 04 Feb 2026 | SALE | Travere Therapeutics, Inc. | 1,635 | 32.14 USD | |
| 31 Jan 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 28,130 | 0.00 USD | |
| 03 Feb 2026 | SALE | Travere Therapeutics, Inc. | 7,242 | 32.12 USD | |
| 31 Jan 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 01 Dec 2025 | SALE | Travere Therapeutics, Inc. | 20,000 | 35.01 USD | |
| 01 Dec 2025 | EXERCISE | Travere Therapeutics, Inc. | 20,000 | 16.23 USD | |
| 01 Dec 2025 | EXERCISE | Travere Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 03 Sept 2025 | SALE | Travere Therapeutics, Inc. | 454 | 18.20 USD | |
| 04 Sept 2025 | SALE | Travere Therapeutics, Inc. | 119 | 19.71 USD | |
| 27 Aug 2025 | SALE | Travere Therapeutics, Inc. | 470 | 17.31 USD | |
| 02 May 2025 | EXERCISE | Travere Therapeutics, Inc. | 4,920 | — | |
| 05 May 2025 | SALE | Travere Therapeutics, Inc. | 1,784 | 21.05 USD | |
| 02 May 2025 | EXERCISE | Travere Therapeutics, Inc. | 4,920 | 0.00 USD | deriv |
| 11 Apr 2025 | SALE | Travere Therapeutics, Inc. | 48 | 13.14 USD | |
| 03 Feb 2025 | SALE | Travere Therapeutics, Inc. | 5,192 | 20.12 USD | |
| 31 Jan 2025 | GRANT_AWARD | Travere Therapeutics, Inc. | 21,500 | 0.00 USD | |
| 31 Jan 2025 | GRANT_AWARD | Travere Therapeutics, Inc. | 58,000 | 0.00 USD | deriv |
| 22 Jan 2025 | SALE | Travere Therapeutics, Inc. | 865 | 18.94 USD | |
| 09 Sept 2024 | SALE | Travere Therapeutics, Inc. | 2,490 | 11.52 USD |